MANKIND PHARMA
Back to Cashflow Statement
|
MANKIND PHARMA Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹3,121 Cr | ₹2,413 Cr | ₹2,152 Cr | ₹1,813 Cr | ₹920 Cr |
What is the latest Cash Flow from Operating Activities ratio of MANKIND PHARMA ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹3,121 Cr |
| Mar2025 | ₹2,413 Cr |
| Mar2024 | ₹2,152 Cr |
| Mar2023 | ₹1,813 Cr |
| Mar2022 | ₹920 Cr |
How is Cash Flow from Operating Activities of MANKIND PHARMA Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹3,121 Cr | 29.33 | |
| Mar2025 | ₹2,413 Cr | 12.12 | |
| Mar2024 | ₹2,152 Cr | 18.70 | |
| Mar2023 | ₹1,813 Cr | 97.15 | |
| Mar2022 | ₹920 Cr | - | |
Compare Cash Flow from Operating Activities of peers of MANKIND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MANKIND PHARMA | ₹91,562.1 Cr | -3.3% | -6.3% | -6.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,204.0 Cr | -0.4% | -6.1% | 5.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹238,497.0 Cr | 0.9% | -3.3% | 39.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹170,481.0 Cr | 0.1% | -7.2% | 28.2% | Stock Analytics | |
| CIPLA | ₹108,012.0 Cr | -0.3% | -4% | -15.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,207.0 Cr | 1.5% | 3.1% | 0.4% | Stock Analytics | |
MANKIND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MANKIND PHARMA | -3.3% |
-6.3% |
-6.7% |
| SENSEX | -1.6% |
-2.3% |
-11.5% |
You may also like the below Video Courses